Synthesis and antitumor activity of some analogues of flavone acetic acid. 1996

P Valenti, and G Fabbri, and A Rampa, and A Bisi, and S Gobbi, and P Da Re, and M Carrara, and A Sgevano, and L Cima
Department of Pharmaceutical Sciences, University of Bologna, Italy.

Some coumarin-, flavonol- and flavanon-acetic acids are described. The cytotoxicity of the synthesized compounds was determined on a human colon carcinoma cell line (LoVo) through evaluation of neutral red uptake, performed by the Riddel method. All tested derivatives were able to induce a statistically significant reduction of lysosomal neutral red uptake at 5 x 10(-5) M concentration. Some compounds were more active than the reference compound flavon-8-acetic acid.

UI MeSH Term Description Entries
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D003374 Coumarins Synthetic or naturally occurring substances related to coumarin, the delta-lactone of coumarinic acid. 1,2-Benzopyrone Derivatives,1,2-Benzopyrones,Coumarin Derivative,Coumarine,1,2-Benzo-Pyrones,Benzopyran-2-ones,Coumarin Derivatives,Coumarines,1,2 Benzo Pyrones,1,2 Benzopyrone Derivatives,1,2 Benzopyrones,Benzopyran 2 ones,Derivative, Coumarin,Derivatives, 1,2-Benzopyrone,Derivatives, Coumarin
D005419 Flavonoids A group of phenyl benzopyrans named for having structures like FLAVONES. 2-Phenyl-Benzopyran,2-Phenyl-Chromene,Bioflavonoid,Bioflavonoids,Flavonoid,2-Phenyl-Benzopyrans,2-Phenyl-Chromenes,2 Phenyl Benzopyran,2 Phenyl Benzopyrans,2 Phenyl Chromene,2 Phenyl Chromenes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000085 Acetates Derivatives of ACETIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxymethane structure. Acetate,Acetic Acid Esters,Acetic Acids,Acids, Acetic,Esters, Acetic Acid
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured

Related Publications

P Valenti, and G Fabbri, and A Rampa, and A Bisi, and S Gobbi, and P Da Re, and M Carrara, and A Sgevano, and L Cima
January 2000, Bioorganic & medicinal chemistry,
P Valenti, and G Fabbri, and A Rampa, and A Bisi, and S Gobbi, and P Da Re, and M Carrara, and A Sgevano, and L Cima
January 2005, Anticancer research,
P Valenti, and G Fabbri, and A Rampa, and A Bisi, and S Gobbi, and P Da Re, and M Carrara, and A Sgevano, and L Cima
August 2003, Journal of medicinal chemistry,
P Valenti, and G Fabbri, and A Rampa, and A Bisi, and S Gobbi, and P Da Re, and M Carrara, and A Sgevano, and L Cima
December 1998, Anti-cancer drug design,
P Valenti, and G Fabbri, and A Rampa, and A Bisi, and S Gobbi, and P Da Re, and M Carrara, and A Sgevano, and L Cima
September 1989, European journal of cancer & clinical oncology,
P Valenti, and G Fabbri, and A Rampa, and A Bisi, and S Gobbi, and P Da Re, and M Carrara, and A Sgevano, and L Cima
May 2001, Die Pharmazie,
P Valenti, and G Fabbri, and A Rampa, and A Bisi, and S Gobbi, and P Da Re, and M Carrara, and A Sgevano, and L Cima
January 1993, Anticancer research,
P Valenti, and G Fabbri, and A Rampa, and A Bisi, and S Gobbi, and P Da Re, and M Carrara, and A Sgevano, and L Cima
January 1991, European journal of cancer (Oxford, England : 1990),
P Valenti, and G Fabbri, and A Rampa, and A Bisi, and S Gobbi, and P Da Re, and M Carrara, and A Sgevano, and L Cima
June 1992, Cancer research,
P Valenti, and G Fabbri, and A Rampa, and A Bisi, and S Gobbi, and P Da Re, and M Carrara, and A Sgevano, and L Cima
March 1990, Journal of the National Cancer Institute,
Copied contents to your clipboard!